Merifin Capital

F2G Ltd develops novel therapies to treat fungal diseases. It primarily focuses on developing an F3 series of anti-mold compound, which is an antifungal agent. The company offers orotomides that are antifungal agents against Aspergillus and other filamentous molds. F2G Ltd was formerly known as Functional Fungal Genomics Ltd and changed its name to F2G Ltd in July 1999. F2G Ltd was founded in 1998 and is based in Manchester, United Kingdom.

DoveConviene S.R.L. designs and develops a digital platform which helps people to shop by saving money through offers and leaflets presented georeferenced manner. The company was founded in 2010 and is based in Sestu, Italy. The startup trades under the brand DoveConviene in Italy and ShopFully in the U.S., as well as various other names in Spain, Brazil, Mexico and Indonesia (TechCrunch).

DoveConviene S.R.L. designs and develops a digital platform which helps people to shop by saving money through offers and leaflets presented georeferenced manner. The company was founded in 2010 and is based in Sestu, Italy. The startup trades under the brand DoveConviene in Italy and ShopFully in the U.S., as well as various other names in Spain, Brazil, Mexico and Indonesia (TechCrunch).

Launched in 2013 in France, Flayr is a unique place for shopping discoveries, allowing people to discover outsourced and crowdsourced edgy little brands and take benefit of great deals on big brands. Flayr is very user-centric, designed only to fulfill their users' every needs. Flayr is developped in Paris, Caen (yes, Caen, Normandy-based city somewhere in France is the new Palo Alto) & USA by Olivier, Nicolas, Philippe, Jerome, Pierre, Delphine, Clémence, Arnaud, Valentin, Jérôme, Antoine, Antoine, Julie, Nabil, Tiphaine, Guillaume, Julien, Isaline, Romain, David, Cassio, and Arthur. France finally found its fourth F: "Fashion, Fragrance, Fromage and Flayr"!

F2G Ltd develops novel therapies to treat fungal diseases. It primarily focuses on developing an F3 series of anti-mold compound, which is an antifungal agent. The company offers orotomides that are antifungal agents against Aspergillus and other filamentous molds. F2G Ltd was formerly known as Functional Fungal Genomics Ltd and changed its name to F2G Ltd in July 1999. F2G Ltd was founded in 1998 and is based in Manchester, United Kingdom.

F2G Ltd develops novel therapies to treat fungal diseases. It primarily focuses on developing an F3 series of anti-mold compound, which is an antifungal agent. The company offers orotomides that are antifungal agents against Aspergillus and other filamentous molds. F2G Ltd was formerly known as Functional Fungal Genomics Ltd and changed its name to F2G Ltd in July 1999. F2G Ltd was founded in 1998 and is based in Manchester, United Kingdom.

Plastic Logic Germany leads the way in developing, manufacturing and commercializing flexible displays. The company has successfully industrialized the manufacturing process in its facility, the world’s first commercial, volume, organic electronics factory. Using a stable and proven licensed technology transistor platform, the company manufactures a range of high-quality, flexible plastic displays. These shatterproof, daylight-readable displays are ultra-thin, ultra-lightweight and very low-power, offering huge advantages over conventional screens as they are extremely robust with proven lifetimes. Plastic Logic Germany also runs an open pilot line for flexible electronics. Third party companies are invited to benefit from the company’s years of experience in the industrialization and manufacture of flexible electronics. Plastic Logic Germany’s customers include OEMs and electronics manufacturers for signage and logistics, mobile electronic devices, smart-cards, wearables and more. For more information, please visit www.plasticlogic.com.

Metara manufactures chemical metrology tools for semiconductor industry that are used in monitoring and controlling chemical processes. Its products include sentry trace contamination metrology system, which monitors benign chemistries for trace contaminants; and sentry chemical composition metrology system, which monitors copper electroplating and cobalt bath chemistries. The company also offers sentry harsh chemistry metrology system, an analysis solution for harsh chemistries used in semiconductor manufacturing processes; and inline mass spectrometer, a chemical metrology solution that determines chemical composition and potential yield-or process-limiting contaminants. Metara Inc. was founded in 2000 and is headquartered in Sunnyvale, California.

DanioLabs Ltd. discovers and develops therapeutics for neurological, ophthalmologic, metabolic, and gastrointestinal diseases.

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing oral therapies for cancer and other proliferative diseases. Founded in 1996 by Professor Sir David Lane, a pioneer in tumor suppressor biology, the company specializes in targeting cell cycle control mechanisms. Its oncology programs include CYC065, a cyclin-dependent kinase inhibitor currently in Phase I trials for solid tumors and chronic lymphocytic leukemia, and CYC140, a polo-like kinase inhibitor also in Phase I trials for advanced leukemias. Additionally, Cyclacel is advancing sapacitabine, an oral nucleoside analogue, through multiple studies, including a Phase III trial for acute myeloid leukemia and combination studies with other agents for patients with BRCA mutations. The company collaborates with the University of Texas MD Anderson Cancer Center to evaluate the safety and efficacy of its drugs in hematological malignancies, and has a partnership with ManRos Therapeutics for the development of oral seliciclib capsules for cystic fibrosis. Cyclacel is headquartered in Berkeley Heights, New Jersey.

Optiva Inc. is a provider of cloud-native revenue management software tailored for communication service providers (CSP) across various global regions, including Europe, the Middle East, Africa, North America, Latin America, the Caribbean, Asia, and the Pacific Rim. The company's solutions facilitate real-time billing, charging, policy management, and enhanced user experiences. Notable products include the Optiva Charging Engine, which aids CSPs in monetizing next-generation services; the Optiva Policy Management solution, designed for data monetization in applications like video streaming and voice over LTE; and Optiva Wholesale Settlement, a cloud solution for accurate interconnect billing. Additionally, Optiva offers e-payment solutions and a comprehensive Business Support Systems Platform for converged billing. Founded in 1999 and headquartered in Mississauga, Canada, Optiva Inc. aims to support the growth and performance of its telecommunications customers through innovative software solutions.